Artificial intelligence can help anticipate risk signals in chronic diseases. In diabetology, however, its effectiveness depends on a often overlooked prerequisite: the quality of clinical data.

Predictive capability is built on complete information collected over time: glycemic trends, therapies and their adjustments, comorbidities, intercurrent events, and longitudinal follow-up. Without this continuity, even the most advanced models provide partial or poorly contextualized results.

For AI to be truly useful, a structured, traceable, and integrated information ecosystem is essential. This means that each data point must have a clear origin (who generated it, when, and in which clinical context), be properly recorded and protected from untracked changes, and not be duplicated across separate systems.

It is also crucial that data collected remotely are integrated into the same electronic health record used in clinical practice, ensuring consistency in documentation and decision-making processes. Only a structured clinical record allows the connection of medical history, tests, therapies, and follow-up, transforming isolated data into meaningful clinical insights.

Predictive medicine, therefore, is not a starting point, but the result of effective data governance. This is the foundation of Meteda’s approach, focused on developing structured electronic health records and longitudinal clinical databases that support a more informed and continuous interpretation of clinical complexity.